Understanding how a gut hormone affects weight loss and health after surgery

The role of intestinal-derived FGF15/19 during obesity and rapid weight loss

NIH-funded research Veterans Health Administration · NIH-11098447

This study is looking at how a hormone called FGF15/19 affects weight loss and possible side effects, like losing bone and muscle, in people who have weight loss surgery, so we can find better ways to help patients after their procedures.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-11098447 on NIH RePORTER

What this research studies

This research investigates the role of the gut hormone FGF15/19 in the context of obesity and weight loss, particularly following bariatric surgery. It aims to understand how this hormone influences weight loss outcomes and potential complications, such as bone and muscle loss, in patients undergoing procedures like Vertical Sleeve Gastrectomy. By using a specialized mouse model, the study will explore the biological mechanisms at play and how they may differ in individuals who have undergone surgery. The findings could provide insights into improving patient care and outcomes after weight loss surgery.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults, particularly veterans, who are considering or have undergone bariatric surgery.

Not a fit: Patients who are not undergoing bariatric surgery or those with conditions unrelated to obesity may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better management strategies for patients undergoing bariatric surgery, potentially reducing complications and improving overall health outcomes.

How similar studies have performed: Other research has shown promising results in understanding the role of gut hormones in weight management, suggesting that this approach could yield significant insights.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions adult onset diabetesAdult-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.